Tuesday, June 22, 2021

NAFDAC to collaborate with Nigerian scientists on COVID-19 drugs, vaccines – DG  


tiamin rice

The National Agency for Food and Drug Administration and Control, NAFDAC, will collaborate with indigenous scientists in the development of drugs or vaccines against the coronavirus disease, COVID-19, in the country.

Prof. Mojisola Adeyeye, NAFDAC Director-General, said the agency’s interventions would allow for documentation of such initiatives for global recording as potential vaccines or drugs that is in process or safety testing.

In an interview with the News Agency of Nigeria on Tuesday in Abuja, she said that the agency would open its doors to the team of Nigerian scientists that declared they are working on a vaccine for COVID-19.

See also  COVID-19: China donates N48m to Nigeria
See also  NAFDAC seals 2 warehouses for recycling expired drugs in Kano

“It will be a great thing if Nigeria develops her vaccine, but all the steps stated above will have to be followed,” she said.

According to her, it takes time to develop a vaccine and NAFDAC will be the first to be informed of any such developments in the country.

“That testing will involve use of the virus and then animals. If all goes well, the researchers will then plan for clinical trial which will take a long time from 18 months to years.

See also  2020 Hajj cancellation: Oyo Board yet to begin refund to intending pilgrims

NAN reports that a team of Nigerian Universities’ Scientists, under the aegis of COVID-19 Research Group, on Friday announced the discovery of the vaccine at Adeleke University, Ede, in Osun.

Dr Oladipo Kolawole, Leader of the team, said the vaccine was being developed locally in Africa for Africans.

Mr Kolawole, a Specialist in Medical Virology, Immunology and Bioinformatics, however, said the vaccine would also work for other continents when unveiled.

He said that the group had been working extensively by exploring the SARS-CoV-2 genome from African countries to select the best possible potential vaccine candidates.

See also  COVID-19: NAFDAC to vet quality of all Chinese medical supplies – Health Minister
See also  Hepatitis patients at higher risk of COVID-19 – WHO

He said that after trying out some selected processes of vaccine development, the researchers were able to choose the best potential vaccine candidates for the SARS-CoV-2 and had made the possible latent vaccine constructs.

On how soon the unnamed vaccine would be unveiled to the public, Mr Kolawole said that it would take a minimum of 18 months.



Related News

Latest News

atrk atrk atrk atrk atrk atrk atrk atrk atrk atrk